相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives
Nathalie Arnal et al.
BRAIN RESEARCH (2010)
Copper in the brain and Alzheimer's disease
Ya Hui Hung et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial
Fred Askari et al.
TRANSLATIONAL RESEARCH (2010)
Longitudinal prognostic value of serum free copper in patients with Alzheimer disease
R. Squitti et al.
NEUROLOGY (2009)
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Peter J. Crouch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease
Rosanna Squitti et al.
PRION (2008)
Dietary copper and high saturated and trans fat intakes associated with cognitive decline
Martha Clare Morris et al.
ARCHIVES OF NEUROLOGY (2006)
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
R. Squitti et al.
NEUROLOGY (2006)
Excess of serum copper not related to ceruloplasmin in Alzheimer disease
R Squitti et al.
NEUROLOGY (2005)
Trace amounts of copper in water induce b-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease
DL Sparks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The magnitude of dementia occurrence in the world
A Wimo et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
分享论文
